| 13 June 2017 | Management of sulfonylurea treated monogenic diabetes in pregnancy: implications of placental Glibenclamide transfer | Shepherd, M; Brook, AJ; Chakera, AJ; et al. |
| 12 October 2017 | Cohort profile for the MASTERMIND study: Using the Clinical Practice Research Datalink (CPRD) to investigate stratification of response to treatment in patients with Type 2 diabetes | Rodgers, LR; Weedon, MN; Henley, WE; et al. |
| 21 July 2017 | Recessively Inherited LRBA Mutations Cause Autoimmunity Presenting as Neonatal Diabetes | Johnson, MB; De Franco, E; Lango Allen, H; et al. |
| 5 August 2017 | Screening for neonatal diabetes at day 5 of life using dried blood spot glucose measurement. | McDonald, TJ; Besser, RE; Perry, M; et al. |
| 16 July 2017 | Neuropsychological impairments in children with KCNJ11 neonatal diabetes | Bowman, P; Hattersley, AT; Knight, BA; et al. |
| 11 September 2017 | Are we missing hypoglycaemia? Elderly patients with insulin-treated diabetes present to primary care frequently with non-specific symptoms associated with hypoglycaemia | Hope, SV; Taylor, PJ; Shields, BM; et al. |
| 30 November 2017 | Frequency and phenotype of type 1 diabetes in the first six decades of life: a cross-sectional, genetically stratified survival analysis from UK Biobank. | Thomas, NJ; Jones, SE; Weedon, MN; et al. |
| 22 December 2017 | Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity. | Turcot, V; Lu, Y; Highland, HM; et al. |
| 1 February 2017 | Rare and low-frequency coding variants alter human adult height | Marouli, E; Graff, M; Medina-Gomez, C; et al. |
| 24 March 2017 | A Low-Frequency Inactivating Akt2 Variant Enriched in the Finnish Population is Associated With Fasting Insulin Levels and Type 2 Diabetes Risk | Manning, A; Highland, HM; Gasser, J; et al. |
